In addition, an increase in the urinary ACE2 expression and activity was demonstrated in patients with diabetic and IgA nephropathies, thus adding value to its diagnostic potential (Mizuiri et al., 2011; Abe et al., 2015). Here, ACE2 is linked to IgA glomerulonephritis.